D
Derek J. Parks
Researcher at Research Triangle Park
Publications - 55
Citations - 11718
Derek J. Parks is an academic researcher from Research Triangle Park. The author has contributed to research in topics: Nuclear receptor & Receptor. The author has an hindex of 37, co-authored 55 publications receiving 11073 citations. Previous affiliations of Derek J. Parks include GlaxoSmithKline.
Papers
More filters
Journal ArticleDOI
Bile Acids: Natural Ligands for an Orphan Nuclear Receptor
Derek J. Parks,Steven G. Blanchard,Randy K. Bledsoe,Gyan Chandra,Thomas G. Consler,Steven A. Kliewer,Julie B. Stimmel,Timothy M. Willson,Ann Marie Zavacki,David D. Moore,Jürgen M. Lehmann +10 more
TL;DR: Results provide evidence for a nuclear bile acid signaling pathway that may regulate cholesterol homeostasis and modulated interaction of FXR with a peptide derived from steroid receptor coactivator 1.
Journal ArticleDOI
Molecular Recognition of Fatty Acids by Peroxisome Proliferator–Activated Receptors
H. Eric Xu,Millard H. Lambert,Valerie G. Montana,Derek J. Parks,Steven G. Blanchard,Peter Brown,Daniel D. Sternbach,Jürgen M. Lehmann,G. Bruce Wisely,Timothy M. Willson,Steven A. Kliewer,Michael V. Milburn +11 more
TL;DR: The peroxisome proliferator-activated receptors (PPARs) are nuclear receptors for fatty acids (FAs) that regulate glucose and lipid homeostasis as mentioned in this paper.
Journal ArticleDOI
Orphan Nuclear Receptors Constitutive Androstane Receptor and Pregnane X Receptor Share Xenobiotic and Steroid Ligands
Linda B. Moore,Derek J. Parks,Stacey A. Jones,Randy K. Bledsoe,Thomas G. Consler,Julie B. Stimmel,Bryan Goodwin,Christopher Liddle,Steven G. Blanchard,Timothy M. Willson,Jon L. Collins,Steven A. Kliewer +11 more
TL;DR: It is demonstrated that several of the compounds that regulate mouse and human CAR, including natural steroids, bind directly to the receptors and suggest that CAR, like PXR, is a steroid receptor that is capable of recognizing structurally diverse compounds.
Journal ArticleDOI
Crystal Structure of the Glucocorticoid Receptor Ligand Binding Domain Reveals a Novel Mode of Receptor Dimerization and Coactivator Recognition
Randy K. Bledsoe,Valerie G. Montana,Thomas B. Stanley,Chris J. Delves,Christopher J. Apolito,David D. McKee,Thomas G. Consler,Derek J. Parks,Eugene L. Stewart,Timothy M. Willson,Millard H. Lambert,John T. Moore,Kenneth H. Pearce,H. Eric Xu +13 more
TL;DR: The crystal structure of the human GR ligand binding domain (LBD) bound to dexamethasone and a coactivator motif derived from the transcriptional intermediary factor 2 is reported to establish a framework for understanding the roles of protein-hormone and protein-protein interactions in GR signaling pathways.
Journal ArticleDOI
6α-Ethyl-Chenodeoxycholic Acid (6-ECDCA), a Potent and Selective FXR Agonist Endowed with Anticholestatic Activity
Roberto Pellicciari,Stefano Fiorucci,Emidio Camaioni,Carlo Clerici,Gabriele Costantino,Patrick R. Maloney,Antonio Morelli,Derek J. Parks,Timothy M. Willson +8 more
TL;DR: 6alpha-ethyl-chenodeoxycholic acid (6-ECDCA) was shown to be a very potent and selective FXR agonist and to be endowed with anticholeretic activity in an in vivo rat model of cholestasis.